A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer. [electronic resource]
Producer: 20120316Description: 2575-2581 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Breast Neoplasms, Male -- drug therapy
- Dasatinib
- Edema -- chemically induced
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
- Paclitaxel -- administration & dosage
- Pleural Effusion, Malignant -- chemically induced
- Pyrimidines -- administration & dosage
- Thiazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.